CatLane
A Delaware jury has sided with Globus Medical (NYSE:GMED), issuing a verdict in favor of the orthopedic product maker in a patent infringement case against its rival Life Spine over the latter’s Prolift family of implants.
In a statement late Thursday, Globus (